BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38084597)

  • 1. Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management.
    González A; López B; Ravassa S; San José G; Latasa I; Butler J; Díez J
    Hypertension; 2024 Feb; 81(2):218-228. PubMed ID: 38084597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growing Heart Failure Burden of Hypertensive Heart Disease: A Call to Action.
    Díez J; Butler J
    Hypertension; 2023 Jan; 80(1):13-21. PubMed ID: 36082670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of myocardial fibrosis in hypertensive heart disease.
    Díez J
    Circ J; 2008; 72 Suppl A():A8-12. PubMed ID: 18772529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of hypertensive myocardial fibrosis.
    Díez J; López B; González A; Querejeta R
    Curr Opin Cardiol; 2001 Nov; 16(6):328-35. PubMed ID: 11704701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hypertensive Myocardium: From Microscopic Lesions to Clinical Complications and Outcomes.
    Moreno MU; Eiros R; Gavira JJ; Gallego C; González A; Ravassa S; López B; Beaumont J; San José G; Díez J
    Med Clin North Am; 2017 Jan; 101(1):43-52. PubMed ID: 27884234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy.
    Frohlich ED; González A; Díez J
    J Hypertens; 2011 Jan; 29(1):17-26. PubMed ID: 21045723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosis and ischemia: the real risks in hypertensive heart disease.
    Frohlich ED
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):194S-199S. PubMed ID: 11411756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy.
    Nwabuo CC; Vasan RS
    Curr Hypertens Rep; 2020 Feb; 22(2):11. PubMed ID: 32016791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Fibrosis in Aortic Stenosis and Hypertensive Heart Disease Assessed by Magnetic Resonance T1 Mapping.
    von Knobelsdorff-Brenkenhoff F; Mueller AK; Prothmann M; Hennig P; Dieringer MA; Schmacht L; Greiser A; Schulz-Menger J
    J Heart Valve Dis; 2016 Sep; 25(5):527-533. PubMed ID: 28238233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain.
    Niu J; Zeng M; Wang Y; Liu J; Li H; Wang S; Zhou X; Wang J; Li Y; Hou F; Zhu J
    BMC Cardiovasc Disord; 2020 Jun; 20(1):292. PubMed ID: 32539749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Imaging of Hypertensive Heart Disease.
    Schumann CL; Jaeger NR; Kramer CM
    Curr Hypertens Rep; 2019 Jan; 21(1):3. PubMed ID: 30637533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus.
    Tadic M; Cuspidi C; Plein S; Milivojevic IG; Wang DW; Grassi G; Mancia G
    Heart Fail Rev; 2021 Nov; 26(6):1383-1390. PubMed ID: 32170529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.
    Brilla CG; Matsubara L; Weber KT
    Hypertension; 1996 Aug; 28(2):269-75. PubMed ID: 8707393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat.
    Xu X; Ding F; Pang J; Gao X; Xu RK; Hao W; Cao JM; Chen C
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(6):H703-11. PubMed ID: 22842067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antihypertensive agents on the left ventricle: clinical implications.
    Díez J; González A; López B; Ravassa S; Fortuño MA
    Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a new paradigm about hypertensive heart disease.
    Díez J
    Med Clin North Am; 2009 May; 93(3):637-45. PubMed ID: 19427496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial collagen remodeling in pressure overload hypertrophy. A case for interstitial heart disease.
    Weber KT; Jalil JE; Janicki JS; Pick R
    Am J Hypertens; 1989 Dec; 2(12 Pt 1):931-40. PubMed ID: 2532916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of arteriolar and myocardial remodelling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy.
    Mundhenke M; Schwartzkopff B; Strauer BE
    Virchows Arch; 1997 Oct; 431(4):265-73. PubMed ID: 9368664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal alterations in cardiac fibroblast function following induction of pressure overload.
    Stewart JA; Massey EP; Fix C; Zhu J; Goldsmith EC; Carver W
    Cell Tissue Res; 2010 Apr; 340(1):117-26. PubMed ID: 20217135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.